Literature DB >> 29370349

Left atrial appendage resection can be performed minimally invasively with good clinical and echocardiographic outcomes without any severe risk.

Takafumi Inoue1,2, Yoshihiro Suematsu2.   

Abstract

OBJECTIVES: The adverse effects of left atrial appendage (LAA) closure have not yet been evaluated. This study aimed to prove the safety and low invasiveness of LAA resection through our thoracoscopic stand-alone left atrial appendectomy experience.
METHODS: Eighty-seven patients [mean age 68 ± 9 years, 68 men (78%), mean congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack to thromboembolism, vascular disease, age 65-74 years and sex category (CHA2DS2-VASc) score 2.9 ± 1.6 points] who had undergone thoracoscopic left atrial appendectomy were selected. The operative and clinical data (left atrial diameter, left ventricular diameter of systole/diastole, ejection fraction, brain natriuretic peptide and human atrial natriuretic peptide) were evaluated. All procedures were performed without cardiopulmonary bypass or cardiac arrest. The LAA was resected with an endoscopic linear cutter device. Except for 1 case with severe pleural adhesion, all operations were performed thoracoscopically.
RESULTS: The preoperative and postoperative data are as follows: left atrial diameter 43 ± 5 mm and 43 ± 5 mm (P = 0.8); left ventricular diameter of systole/diastole 50 ± 5/35 ± 6 mm and 48 ± 5/34 ± 6 mm (P < 0.01); ejection fraction 57 ± 10% and 56 ± 10% (P = 0.11); brain natriuretic peptide 97 ± 77 pg/ml and 72 ± 65 pg/ml (P < 0.01) and human atrial natriuretic peptide 73 ± 64 pg/ml and 96 ± 67 pg/ml (P = 0.03), respectively. The mean volume of bleeding in the operation was very small (<10 ml). The mean length of postoperative in-hospital stay was 3.8 ± 1.8 days. All the patients were discharged while maintaining their preoperative activities of daily living without major complications. No thrombus or residual stumps were detected during the 3-month postoperative computed tomography follow-up. The perioperative heart function did not change significantly in this study. Bleeding with resection was minimal, and no rebleeding events occurred.
CONCLUSIONS: LAA resection did not affect negatively on the cardiac function and did not increase the risk of bleeding risk.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29370349     DOI: 10.1093/ejcts/ezx506

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Sex Differences in Atrial Fibrillation-Update on Risk Assessment, Treatment, and Long-Term Risk.

Authors:  Charlotte J Bai; Nidhi Madan; Shaza Alshahrani; Neelum T Aggarwal; Annabelle Santos Volgman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-27

2.  Poor enhancement pattern of left atrial appendage in cardiac computed tomography is associated with stroke in persistent atrial fibrillation patients.

Authors:  Takafumi Inoue; Yoshihiro Suematsu
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 3.  Does Left Atrial Appendage Amputation During Routine Cardiac Surgery Reduce Future Atrial Fibrillation and Stroke?

Authors:  Helena Domínguez; Christoffer Valdorff Madsen; Oliver Nøhr Hjorth Westh; Peter Appel Pallesen; Christian Lildal Carrranza; Akhmadjon Irmukhamedov; Jesper Park-Hansen
Journal:  Curr Cardiol Rep       Date:  2018-08-31       Impact factor: 2.931

4.  Impact of stand-alone minimally invasive radiofrequency ablation with left atrial appendectomy on left atrial function assessed by echocardiography.

Authors:  Yanjuan Zhang; Haoliang Sun; Mingfang Li; Ming Luo; Fang Xu; Yongfeng Shao; Di Xu
Journal:  Quant Imaging Med Surg       Date:  2020-05

5.  Early and Middle-Term Results and Anticoagulation Strategy after Left Atrial Appendage Exclusion Using an Epicardial Clip Device.

Authors:  Akihiro Yoshimoto; Yoshihiro Suematsu; Kanan Kurahashi; Hiroyuki Kaneko; Daisuke Arima; Satoshi Nishi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-11-19       Impact factor: 1.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.